Moolec Science S.A.
MLEC · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $334 | $6 | $1 | $0 |
| % Growth | 5,830.7% | 521.5% | – | – |
| Cost of Goods Sold | $220 | $5 | $1 | $0 |
| Gross Profit | $114 | $0 | -$0 | $0 |
| % Margin | 34.2% | 8.4% | -15.8% | – |
| R&D Expenses | $9 | $2 | $1 | $1 |
| G&A Expenses | $0 | $7 | $47 | $3 |
| SG&A Expenses | $115 | $7 | $48 | $3 |
| Sales & Mktg Exp. | $0 | $1 | $0 | $0 |
| Other Operating Expenses | $0 | $1 | -$43 | $0 |
| Operating Expenses | $124 | $10 | $7 | $4 |
| Operating Income | -$10 | -$9 | -$7 | -$2 |
| % Margin | -3.1% | -160.8% | -735.2% | – |
| Other Income/Exp. Net | -$160 | $1 | -$45 | $2 |
| Pre-Tax Income | -$170 | -$8 | -$52 | -$0 |
| Tax Expense | $7 | -$1 | -$0 | $0 |
| Net Income | -$111 | -$7 | -$52 | -$5 |
| % Margin | -33.4% | -130% | -5,722.2% | – |
| EPS | -258.75 | -2.85 | -22.5 | -1.8 |
| % Growth | -8,978.9% | 87.3% | -1,150% | – |
| EPS Diluted | -258.75 | -2.85 | -22.5 | -1.8 |
| Weighted Avg Shares Out | 0 | 3 | 2 | 3 |
| Weighted Avg Shares Out Dil | 0 | 3 | 2 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $2 | $1 | $0 |
| Interest Expense | $42 | $1 | $0 | $0 |
| Depreciation & Amortization | $22 | $1 | $0 | $0 |
| EBITDA | -$69 | -$6 | -$52 | -$4 |
| % Margin | -20.7% | -109.5% | -5,717% | – |